Organoid cultures for the analysis of cancer phenotypes

Current Opinion in Genetics and Development

Volumn 24, Issue 1, 2014, Pages 68-73

  Sachs, Norman ^a   Clevers, Hans ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CELL CULTURE; CANCER RESEARCH; HIGH THROUGHPUT SCREENING; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; ORGAN CULTURE TECHNIQUE; ORGANOID CULTURE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TISSUE CULTURE; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; HUMANS; NEOPLASMS; ORGANOIDS; PHENOTYPE; TISSUE CULTURE TECHNIQUES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84891404742     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2013.11.012     Document Type: Review

References (42)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63:11-30.
2. Kamb A. What's wrong with our cancer models?. Nat Rev Drug Discov 2005, 4:161-165.
3. Caponigro G., Sellers W.R. Advances in the preclinical testing of cancer therapeutic hypotheses. Nat Rev Drug Discov 2011, 10:179-187.
4. Cheon D.J., Orsulic S. Mouse models of cancer. Annu Rev Pathol 2011, 6:95-119.
5. Frese K.K., Tuveson D.A. Maximizing mouse cancer models. Nat Rev Cancer 2007, 7:645-658.
6. Gey G.O., Coffman W.D., Kubicek M.T. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res 1952, 12:264-265.
7. Osborne C.K., Hobbs K., Clark G.M. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res 1985, 45:584-590.
8. Johnston S.J., Cheung K.L. Fulvestrant-a novel endocrine therapy for breast cancer. Curr Med Chem 2010, 17:902-914.
9. Greshock J., Bachman K.E., Degenhardt Y.Y., Jing J., Wen Y.H., Eastman S., McNeil E., Moy C., Wegrzyn R., Auger K., Hardwicke M.A., Wooster R. Molecular target class is predictive of in vitro response profile. Cancer Res 2010, 70:3677-3686.
10. Sos M.L., Michel K., Zander T., Weiss J., Frommolt P., Peifer M., Li D., Ullrich R., Koker M., Fischer F., Shimamura T., Rauh D., Mermel C., Fischer S., Stuckrath I., Heynck S., Beroukhim R., Lin W., Winckler W., Shah K., LaFramboise T., Moriarty W.F., Hanna M., Tolosi L., Rahnenfuhrer J., Verhaak R., Chiang D., Getz G., Hellmich M., Wolf J., Girard L., Peyton M., Weir B.A., Chen T.H., Greulich H., Barretina J., Shapiro G.I., Garraway L.A., Gazdar A.F., Minna J.D., Meyerson M., Wong K.K., Thomas R.K. Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions. J Clin Invest 2009, 119:1727-1740.
11. Masters J.R. Human cancer cell lines: fact and fantasy. Nat Rev Mol Cell Biol 2000, 1:233-236.
12. Lacroix M., Leclercq G. Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 2004, 83:249-289.
13. Barretina J., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.K., Yu J., Aspesi P., de S.M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L., Winckler W., Reich M., Li N., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012, 483:603-607.
14. van Staveren W.C., Solis D.Y., Hebrant A., Detours V., Dumont J.E., Maenhaut C. Human cancer cell lines: experimental models for cancer cells in situ? For cancer stem cells?. Biochim Biophys Acta 2009, 1795:92-103.
15. Daniel V.C., Marchionni L., Hierman J.S., Rhodes J.T., Devereux W.L., Rudin C.M., Yung R., Parmigiani G., Dorsch M., Peacock C.D., Watkins D.N. A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer Res 2009, 69:3364-3373.
16. Jin K., Teng L., Shen Y., He K., Xu Z., Li G. Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review. Clin Transl Oncol 2010, 12:473-480.
17. Tentler J.J., Tan A.C., Weekes C.D., Jimeno A., Leong S., Pitts T.M., Arcaroli J.J., Messersmith W.A., Eckhardt S.G. Patient-derived tumour xenografts as models for oncology drug development. Nat Rev Clin Oncol 2012, 9:338-350.
18. Guenot D., Guerin E., Aguillon-Romain S., Pencreach E., Schneider A., Neuville A., Chenard M.P., Duluc I., Du M.S., Brigand C., Oudet P., Kedinger M., Gaub M.P. Primary tumour genetic alterations and intra-tumoral heterogeneity are maintained in xenografts of human colon cancers showing chromosome instability. J Pathol 2006, 208:643-652.
19. Krumbach R., Schuler J., Hofmann M., Giesemann T., Fiebig H.H., Beckers T. Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: activation of MET as one mechanism for drug resistance. Eur J Cancer 2011, 47:1231-1243.
20. Hidalgo M., Bruckheimer E., Rajeshkumar N.V., Garrido-Laguna I., De O.E., Rubio-Viqueira B., Strawn S., Wick M.J., Martell J., Sidransky D. A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer. Mol Cancer Ther 2011, 10:1311-1316.
21. John T., Kohler D., Pintilie M., Yanagawa N., Pham N.A., Li M., Panchal D., Hui F., Meng F., Shepherd F.A., Tsao M.S. The ability to form primary tumor xenografts is predictive of increased risk of disease recurrence in early-stage non-small cell lung cancer. Clin Cancer Res 2011, 17:134-141.
22. Bernards R. A missing link in genotype-directed cancer therapy. Cell 2012, 151:465-468.
23. Sato T., Stange D.E., Ferrante M., Vries R.G., van Es J.H., Van den Brink S., Van Houdt W.J., Pronk A., Van G.J., Siersema P.D., Clevers H. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology 2011, 141:1762-1772.
24. Jung P., Sato T., Merlos-Suarez A., Barriga F.M., Iglesias M., Rossell D., Auer H., Gallardo M., Blasco M.A., Sancho E., Clevers H., Batlle E. Isolation and in vitro expansion of human colonic stem cells. Nat Med 2011, 17:1225-1227.
25. Sato T., Vries R.G., Snippert H.J., van de Wetering M., Barker N., Stange D.E., van Es J.H., Abo A., Kujala P., Peters P.J., Clevers H. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009, 459:262-265.
26. Kuratnik A., Giardina C. Intestinal organoids as tissue surrogates for toxicological and pharmacological studies. Biochem Pharmacol 2013, 85:1721-1726.
27. Sato T., Clevers H. Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications. Science 2013, 340:1190-1194.
28. Dekkers J.F., Wiegerinck C.L., de Jonge H.R., Bronsveld I., Janssens H.M., de Winter-de Groot K.M., Brandsma A.M., de Jong N.W., Bijvelds M.J., Scholte B.J., Nieuwenhuis E.E., Van den Brink S., Clevers H., van der Ent C.K., Middendorp S., Beekman J.M. A functional CFTR assay using primary cystic fibrosis intestinal organoids. Nat Med 2013, 19:939-945.
29. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
30. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
31. Fearon E.R. Molecular genetics of colorectal cancer. Annu Rev Pathol 2011, 6:479-507.
32. Markowitz S.D., Bertagnolli M.M. Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med 2009, 361:2449-2460.
33. Chen J., Li Y., Yu T.S., McKay R.M., Burns D.K., Kernie S.G., Parada L.F. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012, 488:522-526.
34. Driessens G., Beck B., Caauwe A., Simons B.D., Blanpain C. Defining the mode of tumour growth by clonal analysis. Nature 2012, 488:527-530.
35. Schepers A.G., Snippert H.J., Stange D.E., van den Born M., van Es J.H., van de Wetering M., Clevers H. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 2012, 337:730-735.
36. Emmink B.L., Van Houdt W.J., Vries R.G., Hoogwater F.J., Govaert K.M., Verheem A., Nijkamp M.W., Steller E.J., Jimenez C.R., Clevers H., Borel Rinkes I.H., Kranenburg O. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan. Gastroenterology 2011, 141:269-278.
37. Onuma K., Ochiai M., Orihashi K., Takahashi M., Imai T., Nakagama H., Hippo Y. Genetic reconstitution of tumorigenesis in primary intestinal cells. Proc Natl Acad Sci U S A 2013, 110:11127-11132.
38. Sato T., van Es J.H., Snippert H.J., Stange D.E., Vries R.G., van den Born M., Barker N., Shroyer N.F., van de Wetering M., Clevers H. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 2011, 469:415-418.
39. Kleinman H.K., McGarvey M.L., Liotta L.A., Robey P.G., Tryggvason K., Martin G.R. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 1982, 21:6188-6193.
40. Barker N., Huch M., Kujala P., van de Wetering M., Snippert H.J., van Es J.H., Sato T., Stange D.E., Begthel H., van den Born M., Danenberg E., Van den Brink S., Korving J., Abo A., Peters P.J., Wright N., Poulsom R., Clevers H. Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 2010, 6:25-36.
41. Huch M., Dorrell C., Boj S.F., van Es J.H., Li V.S., van de Wetering M., Sato T., Hamer K., Sasaki N., Finegold M.J., Haft A., Vries R.G., Grompe M., Clevers H. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature 2013, 494:247-250.
42. Huch M., Bonfanti P., Boj S.F., Sato T., Loomans C.J., van de Wetering M., Sojoodi M., Li V.S., Schuijers J., Gracanin A., Ringnalda F., Begthel H., Hamer K., Mulder J., van Es J.H., de K.E., Vries R.G., Heimberg H., Clevers H. Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axis. EMBO J 2013, 32:2708-2721.